|
1
|
Louis DN, Ohgaki H, Wiestler OD, Cavenee
WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007
WHO classification of tumours of the central nervous system. Acta
Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hemminki K and Li X: Familial risks in
nervous system tumors. Cancer Epidemiol Biomarkers Prev.
12:1137–1142. 2003.PubMed/NCBI
|
|
3
|
Scheurer ME, Etzel CJ, Liu M, El-Zein R,
Airewele GE, Malmer B, Aldape KD, Weinberg JS, Yung WK and Bondy
ML: Aggregation of cancer in first-degree relatives of patients
with glioma. Cancer Epidemiol Biomarkers Prev. 16:2491–2495. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bondy ML, Scheurer ME, Malmer B,
Barnholtz-Sloan JS, Davis FG, Il'yasova D, Kruchko C, McCarthy BJ,
Rajaraman P, Schwartzbaum JA, et al: Brain tumor epidemiology:
consensus from the brain tumor epidemiology consortium. Cancer.
113:1953–1968. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shete S, Hosking FJ, Robertson LB, Dobbins
SE, Sanson M, Malmer B, Simon M, Marie Y, Boisselier B, Delattre
JY, et al: Genome-wide association study identifies five
susceptibility loci for glioma. Nat Genet. 41:899–904. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wrensch M, Jenkins RB, Chang JS, Yeh RF,
Xiao Y, Decker PA, Ballman KV, Berger M, Buckner JC, Chang S, et
al: Variants in the CDKN2B and RTEL1 regions are associated with
high-grade glioma susceptibility. Nat Genet. 41:905–908. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Egan KM, Thompson RC, Nabors LB, Olson JJ,
Brat DJ, Larocca RV, Brem S, Moots PL, Madden MH, Browning JE and
Ann Chen Y: Cancer susceptibility variants and the risk of adult
glioma in a US case-control study. J Neurooncol. 104:535–542. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ryan BM, Robles AI and Harris CC: Genetic
variation in microRNA networks: the implications for cancer
research. Nat Rev Cancer. 10:389–402. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang Q, Jie Z, Ye S, Li Z, Han Z, et al:
Genetic variations in miR-27a gene decrease mature miR-27a level
and reduce gastric cancer susceptibility. Oncogene. 33:193–202.
2014. View Article : Google Scholar
|
|
11
|
Jazdzewski K, Murray EL, Franssila K,
Jarzab B, Schoenberg DR, et al: Common SNP in pre-miR-146a
decreases mature miR expression and predisposes to papillary
thyroid carcinoma. Proc Natl Acad Sci USA. 105:7269–7274. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Turner JD, Williamson R, Almefty KK,
Nakaji P, Porter R, Tse V and Kalani MY: The many roles of
microRNAs in brain tumor biology. Neurosurg Focus. 28:E32010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Duan R, Pak C and Jin P: Single nucleotide
polymorphism associated with mature miR-125a alters the processing
of pri-miRNA. Hum Mol Genet. 16:1124–1131. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chae YS, Kim JG, Lee SJ, Kang BW, Lee YJ,
Park JY, Jeon HS, Park JS and Choi GS: A miR-146a polymorphism
(rs2910164) predicts risk of and survival from colorectal cancer.
Anticancer Res. 33:3233–3239. 2013.PubMed/NCBI
|
|
15
|
Chen L, Zhang R, Li P, Liu Y, Qin K, Fa
ZQ, Liu YJ, Ke YQ and Jiang XD: P53-induced microRNA-107 inhibits
proliferation of glioma cells and down-regulates the expression of
CDK6 and Notch-2. Neurosci Lett. 534:327–332. 2013. View Article : Google Scholar
|
|
16
|
Zhang X, Chen T, Zhang J, Mao Q, Li S,
Xiong W, Qiu Y, Xie Q and Ge J: Notch1 promotes glioma cell
migration and invasion by stimulating β-catenin and NF-κB signaling
via AKT activation. Cancer Sci. 103:181–190. 2012. View Article : Google Scholar
|
|
17
|
Mei J, Bachoo R and Zhang CL:
MicroRNA-146a inhibits glioma development by targeting Notch1. Mol
Cell Biol. 31:3584–3592. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Treanor LM, Volanakis EJ, Zhou S, Lu T,
Sherr CJ and Sorrentino BP: Functional interactions between Lmo2,
the Arf tumor suppressor and Notch1 in murine T-cell malignancies.
Blood. 117:5453–5462. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Permuth-Wey J, Thompson RC, Burton Nabors
L, Olson JJ, Browning JE, Madden MH, Ann Chen Y and Egan KM: A
functional polymorphism in the pre-miR-146a gene is associated with
risk and prognosis in adult glioma. J Neurooncol. 105:639–646.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xu B, Feng NH, Li PC, Tao J, Wu D, Zhang
ZD, Tong N, Wang JF, Song NH, Zhang W, Hua LX and Wu HF: A
functional polymorphism in Pre-miR-146a gene is associated with
prostate cancer risk and mature miR-146a expression in vivo.
Prostate. 70:467–472. 2010. View Article : Google Scholar
|
|
21
|
Xu P, Zhang A, Jiang R, Qiu M, Kang C, Jia
Z, Wang G, Han L, Fan X and Pu P: The different role of Notch1 and
Notch2 in astrocytic gliomas. PLoS One. 8:e536542013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xu T, Zhu Y, Wei QK, Yuan Y, Zhou F, Ge
YY, Yang JR, Su H and Zhuang SM: A functional polymorphism in the
miR-146a gene is associated with the risk for hepatocellular
carcinoma. Carcinogenesis. 29:2126–2131. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Guo H, Wang K, Xiong G, Hu H, Wang D, Xu
X, Guan X, Yang K and Bai Y: A functional varient in microRNA-146a
is associated with risk of esophageal squamous cell carcinoma in
Chinese Han. Fam Cancer. 9:559–603. 2010. View Article : Google Scholar
|
|
24
|
Okubo M, Tahara T, Shibata T, Yamashita H,
Nakamura M, Yoshioka D, Yonemura J, Kamiya Y, Ishizuka T, Nakagawa
Y, et al: Association study of common genetic variants in
pre-microRNAs in patients with ulcerative colitis. J Clin Immunol.
31:69–73. 2011. View Article : Google Scholar
|
|
25
|
Zeng Y, Sun QM, Liu NN, Dong GH, Chen J,
Yang L and Wang B: Correlation between premiR-146a C/G polymorphism
and gastric cancer risk in Chinese population. World J
Gastroenterol. 16:3578–3583. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shen J, Ambrosone CB, DiCioccio RA, Odunsi
K, Lele SB and Zhao H: A functional polymorphism in the miR-146a
gene and age of familial breast/ovarian cancer diagnosis.
Carcinogenesis. 29:1963–1966. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Iyer A, Zurolo E, Prabowo A, Fluiter K,
Spliet WGM, van Rijen PC, Gorter JA and Aronica E: MicroRNA-146a: a
key regulator of astrocyte-mediated inflammatory response. PLoS
One. 7:e447892012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Peng Z, Shuangzhu Y, Yongjie J, Xinjun Z
and Ying L: TNF receptor-associated factor 6 regulates
proliferation, apoptosis, and invasion of glioma cells. Mol Cell
Biochem. 377:87–96. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Funakoshi M, Sonoda Y, Tago K, Tominaga S
and Kasahara T: Differential involvement of p38 mitogen-activated
protein kinase and phosphatidyl inositol 3-kinase in the
IL-1-mediated NF-kappaB and AP-1 activation. Int Immunopharmacol.
1:595–604. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sun H, Li XB, Meng Y, Fan L, Li M and Fang
J: TRAF6 upregulates expression of HIF-1α and promotes tumor
angiogenesis. Cancer Res. 73:4950–4959. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yao F, Han Q, Zhong C and Zhao H: TRAF6
promoted the tumorigenicity of esophageal squamous cell carcinoma.
Tumour Biol. 34:3201–3207. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu H, Tamashiro S, Baritaki S, Penichet
M, Yu Y, Chen H, Berenson J and Bonavida B: TRAF6 activation in
multiple myeloma: a potential therapeutic target. Clin Lymphoma
Myeloma Leuk. 12:155–163. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu H, Zhang T, Ye J, Li H, Huang J, Li X,
Wu B, Huang X and Hou J: TNF receptor-associated factor 6 in
advanced non-small cell lung cancer: clinical and prognostic
implications. J Cancer Res Clin Oncol. 138:1853–1863. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hori K, Sen A and Artavanis-Tsakonas S:
Notch signaling at a glance. J Cell Sci. 126:2135–2140. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Boulay JL, Miserez AR, Zweifel C,
Sivasankaran B, Kana V, Ghaffari A, Luyken C, Sabel M, Zerrouqi A,
Wasner M, et al: Loss of NOTCH2 positively predicts survival in
subgroups of human glial brain tumors. PLoS One. 2:e5762007.
View Article : Google Scholar : PubMed/NCBI
|
